Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

34,475 stories, page 37 of 575

Advanced search

🌍5d agodiscoverynews.google.com

Amivantamab plus chemotherapy achieves 34.3-month OS in EGFR exon 20 insertion lung cancer

The Clinical Trial VanguardOriginal source

🌍5d agodiscoverynews.google.com

Tam-Peli Extends Survival to 13.3 Months in Relapsed Small-Cell Lung Cancer

clinicaltrialvanguard.comOriginal source

🌍5d agodiscoverynews.google.com

MRI Surveillance Alone Outperforms MRI Plus Radiation in SCLC Trial

The Clinical Trial VanguardOriginal source

🌍5d agodiscoverynews.google.com

Emmaus, Cedars-Sinai Extend Pact

Los Angeles Business JournalOriginal source

🌍5d agodiscoverynews.google.com

Challenges Facing Chinese Biotech Deals

chinalawandpractice.comOriginal source

🌍5d agodiscoverynews.google.com

South Korean pharmaceutical company plans to produce medicines in Kazakhstan

Kursiv MediaOriginal source

🌍5d agodiscoverynews.google.com

Kazakhstan and South Korea agree on joint pharmaceutical production

AzərtacOriginal source

🌍5d agodiscoverynews.google.com

Takeda’s Zasocitinib Wins FDA Priority Review in Bid to Redefine Oral Psoriasis Care

TipRanksOriginal source

🌍5d agodiscoverynews.google.com

Kazakhstan and South Korea agree on joint pharmaceutical production

QazinformOriginal source

🇳🇱5d agoResearcheur.nl

This is what Rotterdam needs to become the best city in which to grow up

Erasmus University RotterdamOriginal source

🌍5d agodiscoverynews.google.com

Spotlight on ‘Innovative Pharmaceutical Companies’ After Drug Pricing Reform... Alteogen and ABL Among Certified Firms

아시아경제Original source

🌍5d agodiscoverynews.google.com

FDA approves new brain cancer imaging agent from Telix

Radiology BusinessOriginal source

🌍5d agoRegulatoryeof.gr

Συμμετοχή του ΕΟΦ στην 90η ΔΕΘ.

EOF GreeceOriginal source

🇪🇸5d agoResearchclinicbarcelona.org

“I started getting migraines when I was only seven.”

Hospital Clínic de BarcelonaOriginal source

🌍5d agodiscoverynews.google.com

U.S. FDA Accepts New Drug Application Under Priority Review for Takeda’s Zasocitinib in Moderate-to-Severe Plaque Psoriasis, with Potential to Redefine Oral Treatment Expectations

Business WireOriginal source

🌍5d agoIndustryhealth.ucdavis.edu

Spirit Halloween raises funds for UC Davis Child Life

UC Davis HealthOriginal source

🌍5d agoRegulatoryifpma.org

Statement on PABS Instrument at the eighth meeting of the Intergovernmental Working Group (IGWG 8) on the WHO Pandemic Agreement

IFPMA GlobalOriginal source

🇸🇪5d agoResearchvgrfokus.se

Preliminärt resultat i regionvalet

Sahlgrenska SwedenOriginal source

🌍5d agodiscoverynews.google.com

Trump's drug plan could prompt companies to raise prices outside the US

medwatch.comOriginal source

🌍5d agodiscoverynews.google.com

Kenya Explores Merck Partnership in Biotechnology and Local Pharmaceutical Manufacturing

health.go.keOriginal source

🇧🇪5d agoRegulatoryfamhp.be

Nouveau guide destiné aux promoteurs pour la procédure synchronisée des études combinées CTR–MDR/IVDR

FAMHP BelgiumOriginal source

🌍5d agodiscoverynews.google.com

Trastuzumab Botidotin Shows 11.1-Month PFS vs T-DM1 in Phase 3 Trial

The Clinical Trial VanguardOriginal source

🌍5d agodiscoverynews.google.com

Three Biotech Catalysts To Watch This Fall: RARE, RAPP And PCVX (NASDAQ:RARE)

Seeking AlphaOriginal source

🌍5d agodiscoverynews.google.com

Santen Pharmaceutical : New Drug Application Filing Accepted for Review in China for STN1012700 (Atropine Sulfate Ophthalmic Solution 0.025%), an Ophthalmic Solution to Slow the Progression of Myopia

marketscreener.comOriginal source

🇯🇵5d agoResearchjsmo.or.jp

がん免疫薬物療法マネジメントセミナーベーシックコース（12月6日開催）

Japanese Society of Medical OncologyOriginal source

🌍5d agodiscoverynews.google.com

Fourth Russian attack on pharmaceutical warehouse this month: facility on fire in Odesa

Українська правдаOriginal source

🌍5d agodiscoverynews.google.com

Huons Teams Up with Three Biotech Startups for Joint New Drug Development... "Expanding External Research Model"

아시아경제Original source

🇯🇵5d agoIndustrychugai-pharm.co.jp

人事のお知らせ

Chugai Pharmaceutical NewsOriginal source

🇯🇵5d agoIndustrychugai-pharm.co.jp

Personnel Changes

Chugai PharmaceuticalOriginal source

🇧🇪5d agoRegulatoryfamhp.be

Guide destiné aux promoteurs pour la procédure synchronisée des études combinées CTR–MDR/IVDR

FAMHP BelgiumOriginal source

🌍5d agodiscoverynews.google.com

9lione, a Pharmaceutical Distribution DX Company, Raises ¥120 Million in Series A Led by Yokohama Capital

BRIDGE（ブリッジ）Original source

🌍5d agodiscoverynews.google.com

RTW Biotech Opportunities reports August NAV of $2.92 per share By Investing.com

Investing.com IndiaOriginal source

🌍5d agoIndustryavacta.com

Avacta Appoints Mats Blom to the Board of Directors as Chair of Audit Committee

Avacta GroupOriginal source

🌍5d agodiscoverynews.google.com

REG - RTW Biotech Opp. - Monthly Valuation Update and Factsheet

TradingViewOriginal source

🇫🇷5d agoResearchinserm.fr

Violetta Zujovic : les neurosciences sur plusieurs fronts

InsermOriginal source

🌍5d agodiscoverynews.google.com

Yuhan Corporation Unveils Clinical Trial Design for Oral HER2 Cancer Drug YH42946; Phase 2 Set for Early Next Year

finance.biggo.comOriginal source

🌍5d agodiscoverynews.google.com

FDA delays review of Exelixis' zanzalintinib by 3 months, no new safety issues found

PluangOriginal source

🌍5d agodiscoverynews.google.com

Daewon Pharmaceutical Hosts Vietnamese Delegation at Smart Factory

Seoul Economic DailyOriginal source

🇯🇵5d agoResearchhosp.tohoku.ac.jp

第223回仙台心臓血管研究会開催のお知らせ（10/7開催）

Tohoku University HospitalOriginal source

🌍5d agodiscoverynews.google.com

Price to earnings forward of CMG Pharmaceutical Co., Ltd. – KRX:058820

TradingViewOriginal source

🌍5d agodiscoverynews.google.com

FDA Approves ViiV’s Tivicay PD for Newborn HIV Patients

zenopa.comOriginal source

🇯🇵5d agoResearchtohoku.ac.jp

カテーテル治療中の医療従事者を放射線被ばくから守る「壁付ドレープ」を開発 ―軽量な防護具で患者の負担と医療従事者の被ばくを軽減―

Tohoku University HospitalOriginal source

🌍5d agodiscoverynews.google.com

Allan Shaw: Biotech's Real Risk Isn't Dilution — It's Building a 'Brand of Generic'

finance.biggo.comOriginal source

🌍5d agodiscoverynews.google.com

Noxopharm moves lupus skin therapy toward next human trial

biotechdispatch.com.auOriginal source

🇯🇵5d agoResearchhosp.tohoku.ac.jp

2026年度東北大学病院緩和医療セミナー開催のお知らせ（10/31開催）

Tohoku University HospitalOriginal source

🌍5d agodiscoverynews.google.com

4 Best Gene-Editing Stocks for 2026 and How to Invest

The Motley FoolOriginal source

🌍5d agodiscoverynews.google.com

Rebuilding Food Safety Regulation in the United States

The Regulatory ReviewOriginal source

🇦🇺5d agoResearchnews.flinders.edu.au

Two Years On

Flinders University - Health & MedOriginal source

🌍5d agodiscoverynews.google.com

Ivonescimab Monotherapy Demonstrates a Statistically Significant & Clinically Meaningful Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in Akeso’s HARMONi-2 Study Conducted in China

BioSpaceOriginal source

🌍5d agodiscoverynews.google.com

Zipalertinib Plus Chemotherapy Demonstrates 6-Month Median Progression-Free Survival Benefit in REZILIENT3 Phase 3 Trial in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer

BioSpaceOriginal source

🌍5d agodiscoverynews.google.com

AstraZeneca's drug delayed lung cancer progression by 6 months in a trial

Stock TitanOriginal source

🌍5d agodiscoverynews.google.com

China warns US over alleged espionage targeting AI, chip, biotech companies

MLexOriginal source

🌍5d agodiscoverynews.google.com

79% were alive eight years later on AstraZeneca's lung-cancer drug, versus 64% on placebo.

Stock TitanOriginal source

🌍5d agodiscoverynews.google.com

Phase 3 DESTINY-Lung04 trial shows first-line trastuzumab deruxtecan significantly improves progression-free survival in HER2-mutant NSCLC

EurekAlert!Original source

🌍5d agoRegulatorypharmac.govt.nz

Pharmac proposal to improve access to medicines for people with high blood pressure and bacterial infections

Pharmac New ZealandOriginal source

🌍5d agodiscoverynews.google.com

Cullinan, Taiho showcase 6-month survival benefit in phase 3 trial for advanced lung cancer

Fierce BiotechOriginal source

🌍5d agodiscoverynews.google.com

AI-Driven Pharmaceutical R&D Infrastructure Competition: Key Trends, Strategies & Industry Impact

36KrOriginal source

🌍5d agodiscoverynews.google.com

The eastward shift in the biotech world: Why India and China could lead the next wave

Asian Business ReviewOriginal source

🌍5d agodiscoverynews.google.com

Takeda's New Drug Application for Zasocitinib Receives FDA Priority Review

intellectia.aiOriginal source

🇯🇵5d agoIndustrytaiho.co.jp

Zipalertinib Plus Chemotherapy Demonstrates 6-Month Median Progression-Free Survival Benefit in REZILIENT3 Phase 3 Trial in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer

Otsuka Holdings RSSOriginal source

Pharmaceutical industry news

Amivantamab plus chemotherapy achieves 34.3-month OS in EGFR exon 20 insertion lung cancer

Tam-Peli Extends Survival to 13.3 Months in Relapsed Small-Cell Lung Cancer

MRI Surveillance Alone Outperforms MRI Plus Radiation in SCLC Trial

Emmaus, Cedars-Sinai Extend Pact

Challenges Facing Chinese Biotech Deals

South Korean pharmaceutical company plans to produce medicines in Kazakhstan

Kazakhstan and South Korea agree on joint pharmaceutical production

Takeda’s Zasocitinib Wins FDA Priority Review in Bid to Redefine Oral Psoriasis Care

Kazakhstan and South Korea agree on joint pharmaceutical production

This is what Rotterdam needs to become the best city in which to grow up

Spotlight on ‘Innovative Pharmaceutical Companies’ After Drug Pricing Reform... Alteogen and ABL Among Certified Firms

FDA approves new brain cancer imaging agent from Telix

Συμμετοχή του ΕΟΦ στην 90η ΔΕΘ.

“I started getting migraines when I was only seven.”

U.S. FDA Accepts New Drug Application Under Priority Review for Takeda’s Zasocitinib in Moderate-to-Severe Plaque Psoriasis, with Potential to Redefine Oral Treatment Expectations

Spirit Halloween raises funds for UC Davis Child Life

Statement on PABS Instrument at the eighth meeting of the Intergovernmental Working Group (IGWG 8) on the WHO Pandemic Agreement

Preliminärt resultat i regionvalet

Trump's drug plan could prompt companies to raise prices outside the US

Kenya Explores Merck Partnership in Biotechnology and Local Pharmaceutical Manufacturing

Nouveau guide destiné aux promoteurs pour la procédure synchronisée des études combinées CTR–MDR/IVDR

Trastuzumab Botidotin Shows 11.1-Month PFS vs T-DM1 in Phase 3 Trial

Three Biotech Catalysts To Watch This Fall: RARE, RAPP And PCVX (NASDAQ:RARE)

Santen Pharmaceutical : New Drug Application Filing Accepted for Review in China for STN1012700 (Atropine Sulfate Ophthalmic Solution 0.025%), an Ophthalmic Solution to Slow the Progression of Myopia

がん免疫薬物療法マネジメントセミナー ベーシックコース（12月6日開催）

Fourth Russian attack on pharmaceutical warehouse this month: facility on fire in Odesa

Huons Teams Up with Three Biotech Startups for Joint New Drug Development... "Expanding External Research Model"

人事のお知らせ

Personnel Changes

Guide destiné aux promoteurs pour la procédure synchronisée des études combinées CTR–MDR/IVDR

9lione, a Pharmaceutical Distribution DX Company, Raises ¥120 Million in Series A Led by Yokohama Capital

RTW Biotech Opportunities reports August NAV of $2.92 per share By Investing.com

Avacta Appoints Mats Blom to the Board of Directors as Chair of Audit Committee

REG - RTW Biotech Opp. - Monthly Valuation Update and Factsheet

Violetta Zujovic : les neurosciences sur plusieurs fronts

Yuhan Corporation Unveils Clinical Trial Design for Oral HER2 Cancer Drug YH42946; Phase 2 Set for Early Next Year

FDA delays review of Exelixis' zanzalintinib by 3 months, no new safety issues found

Daewon Pharmaceutical Hosts Vietnamese Delegation at Smart Factory

第223回 仙台心臓血管研究会開催のお知らせ（10/7開催）

Price to earnings forward of CMG Pharmaceutical Co., Ltd. – KRX:058820

FDA Approves ViiV’s Tivicay PD for Newborn HIV Patients

カテーテル治療中の医療従事者を放射線被ばくから守る 「壁付ドレープ」を開発 ―軽量な防護具で患者の負担と医療従事者の被ばくを軽減―

Allan Shaw: Biotech's Real Risk Isn't Dilution — It's Building a 'Brand of Generic'

Noxopharm moves lupus skin therapy toward next human trial

2026年度東北大学病院緩和医療セミナー開催のお知らせ（10/31開催）

4 Best Gene-Editing Stocks for 2026 and How to Invest

Rebuilding Food Safety Regulation in the United States

Two Years On

Ivonescimab Monotherapy Demonstrates a Statistically Significant & Clinically Meaningful Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in Akeso’s HARMONi-2 Study Conducted in China

Zipalertinib Plus Chemotherapy Demonstrates 6-Month Median Progression-Free Survival Benefit in REZILIENT3 Phase 3 Trial in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer

AstraZeneca's drug delayed lung cancer progression by 6 months in a trial

China warns US over alleged espionage targeting AI, chip, biotech companies

79% were alive eight years later on AstraZeneca's lung-cancer drug, versus 64% on placebo.

Phase 3 DESTINY-Lung04 trial shows first-line trastuzumab deruxtecan significantly improves progression-free survival in HER2-mutant NSCLC

Pharmac proposal to improve access to medicines for people with high blood pressure and bacterial infections

Cullinan, Taiho showcase 6-month survival benefit in phase 3 trial for advanced lung cancer

AI-Driven Pharmaceutical R&D Infrastructure Competition: Key Trends, Strategies & Industry Impact

The eastward shift in the biotech world: Why India and China could lead the next wave

Takeda's New Drug Application for Zasocitinib Receives FDA Priority Review

Zipalertinib Plus Chemotherapy Demonstrates 6-Month Median Progression-Free Survival Benefit in REZILIENT3 Phase 3 Trial in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer

がん免疫薬物療法マネジメントセミナーベーシックコース（12月6日開催）

第223回仙台心臓血管研究会開催のお知らせ（10/7開催）

カテーテル治療中の医療従事者を放射線被ばくから守る「壁付ドレープ」を開発 ―軽量な防護具で患者の負担と医療従事者の被ばくを軽減―